Envigo Bioproducts Inc.
Indianapolis, IN Part of Envigo RMS LLC
- UEI
- YJUGUP5M8966
- CAGE
- 3NRX3
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Envigo RMS LLC, ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 112990 All Other Animal Production
- 311119 Other Animal Food Manufacturing
- 325412 Pharmaceutical Preparation Manufacturing
- 325414 Biological Product (except Diagnostic) Manufacturing
- 541380 Testing Laboratories and Services
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 611310 Colleges, Universities, and Professional Schools
- 622110 General Medical and Surgical Hospitals
- Corporate family
-
-
Parent
Envigo RMS LLC · Indianapolis, IN
E7TPXFCLHSU6
-
Parent
Envigo RMS LLC · Indianapolis, IN
E7TPXFCLHSU6
- SAM.gov registration date
- Physical address
- 8520 Allison Pointe Blvd #400, Indianapolis, IN 46250, USA
- Website
- inotivco.com
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $17,007 |
| FY2024 | -$202 |
| FY2023 | -$4,845 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Envigo Bioproducts Inc. is a for-profit corporate entity registered in SAM.gov since 2003, specializing in biomedical research services and product development. As a discovery and development contract research organization (CRO), the company provides specialized scientific services primarily focused on biological research materials and laboratory support. The company is a child entity, currently registered with a SAM.gov expiration date of March 17, 2026, and operates from its headquarters in Indianapolis, Indiana.
The company has consistently secured federal contract awards primarily from the U.S. Department of Agriculture (USDA) Agricultural Research Service's Midwest Area, with a focus on hybridoma services, cell line storage, and biological research support. Specific contract awards have included hybridoma production in mice, polyclonal antibody production, cryostorage of cell line vials, and cell line storage services. These contracts have ranged in value from $3,325 to $22,655, with completion dates extending through May 2025. The contracts have consistently been structured as purchase orders without any specific set-aside designations, indicating open competition for these research support services.
Envigo Bioproducts Inc. holds a significant $10 million single-award Blanket Purchase Agreement (BPA) with the Department of Health and Human Services' National Institutes of Health (NIH) Office of Logistics and Acquisition Operations, effective through March 2026. This BPA allows the company to provide tissue materials, biologicals, blood products, and animal products to support NIH research initiatives. The company has also engaged in multiple sub-contract awards related to mouse procurement, further demonstrating its role in supporting scientific research infrastructure. These federal contract IDVs highlight Envigo Bioproducts Inc.'s strategic positioning as a specialized provider of biological research materials and services to key federal scientific agencies.
SBA capabilities narrative
RODENT TISSUES, SERA AND PLASMA, FETAL BOVINE SERUM, GROWTH FACTORS, MONOCLONAL/POLYCLONAL ANTIBODIES, CUSTOM MONOCLONAL ANTIBODY DEVELOPMENT, HYBRIDOMA DEVELOPMENT PURIFICATION, CUSTOM LAB SERVICES SUCH AS MAP TESTING, FILTRATION, STERILITY TESTING, ISG
Quick answers
Is Envigo Bioproducts Inc. registered in SAM.gov?
Yes. Envigo Bioproducts Inc.'s SAM.gov registration is active through March 9, 2027.
How much has Envigo Bioproducts Inc. received in federal contracts?
Federal contracts obligated $17,007 to Envigo Bioproducts Inc. in fiscal year 2025 and $11,960 in fiscal years 2023 through 2027.
How does Envigo Bioproducts Inc. rank among federal contractors?
Envigo Bioproducts Inc.'s parent company, Envigo RMS LLC, ranked #6 in NAICS 311119, #7 in NAICS 3111 and #22 in NAICS 321999 in FY2025.
What is Envigo Bioproducts Inc.'s most recent federal award?
Envigo Bioproducts Inc.'s most recent federal contract award is MPM unit - stages 1, 2, 3 - hybridoma services with additional options; stage 1, stage 2, stage 3 (12505B24P0095), from Midwest Area (FRIID), on June 1, 2024.
On GovTribe
See Envigo Bioproducts Inc.'s full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors